Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Binder

Showing results (51-60 of 96) with videos related to

Pageof 10
Sort By:
Medrxiv : the Preprint Server for Health Sciences|April 8, 2025
Artificial Intelligence Prediction of Age from Echocardiography as a Marker for Cardiovascular DiseaseMeenal Rawlani, Hirotaka Ieki, Christina Binder, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 16, 2024
Cardiopulmonary exercise testing in transthyretin amyloid cardiomyopathy patients: a long-term follow-up studyRobin Willixhofer, René Rettl, Christina Kronberger, et al.
Journal of Personalized Medicine|June 2, 2021
Renin Feedback Is an Independent Predictor of Outcome in HFpEFChristina Binder, Marko Poglitsch, Franz Duca, et al.
Journal of Clinical Medicine|November 18, 2020
What Type of Patients Did PARAGON-HF Select? Insights from a Real-World Prospective Cohort of Patients with Heart Failure and Preserved Ejection FractionRené Rettl, Theresa-Marie Dachs, Franz Duca, et al.
JACC. Cardiovascular Imaging|March 18, 2019
Determinants of Bioprosthetic Aortic Valve DegenerationChristian Nitsche, Andreas A Kammerlander, Klaus Knechtelsdorfer, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 11, 2020
Prognostic implications of pericardial and pleural effusion in patients with cardiac amyloidosisChristina Binder, Franz Duca, Thomas Binder, et al.
European Heart Journal. Cardiovascular Imaging|March 7, 2023
Monitoring tafamidis treatment with quantitative SPECT/CT in transthyretin amyloid cardiomyopathyRené Rettl, Tim Wollenweber, Franz Duca, et al.
JACC. Cardiovascular Imaging|November 19, 2018
Diagnostic and Prognostic Utility of Cardiac Magnetic Resonance Imaging in Aortic RegurgitationAndreas A Kammerlander, Matthias Wiesinger, Franz Duca, et al.
NPJ Digital Medicine|November 18, 2025
Artificial intelligence prediction of age from echocardiography as a marker for cardiovascular diseaseMeenal Rawlani, Hirotaka Ieki, Christina Binder, et al.
Scientific Reports|May 4, 2026
Fibroblast growth factor 23 is associated with cardiac disease severity in transthyretin amyloid cardiomyopathyMahshid Eslami, Nikita Ermolaev, Christina Kronberger, et al.
Pageof 10

Showing results (51-60 of 96) with videos related to

Sort By:
Pageof 10
Medrxiv : the Preprint Server for Health Sciences|April 8, 2025
Artificial Intelligence Prediction of Age from Echocardiography as a Marker for Cardiovascular DiseaseMeenal Rawlani, Hirotaka Ieki, Christina Binder, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 16, 2024
Cardiopulmonary exercise testing in transthyretin amyloid cardiomyopathy patients: a long-term follow-up studyRobin Willixhofer, René Rettl, Christina Kronberger, et al.
Journal of Personalized Medicine|June 2, 2021
Renin Feedback Is an Independent Predictor of Outcome in HFpEFChristina Binder, Marko Poglitsch, Franz Duca, et al.
Journal of Clinical Medicine|November 18, 2020
What Type of Patients Did PARAGON-HF Select? Insights from a Real-World Prospective Cohort of Patients with Heart Failure and Preserved Ejection FractionRené Rettl, Theresa-Marie Dachs, Franz Duca, et al.
JACC. Cardiovascular Imaging|March 18, 2019
Determinants of Bioprosthetic Aortic Valve DegenerationChristian Nitsche, Andreas A Kammerlander, Klaus Knechtelsdorfer, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 11, 2020
Prognostic implications of pericardial and pleural effusion in patients with cardiac amyloidosisChristina Binder, Franz Duca, Thomas Binder, et al.
European Heart Journal. Cardiovascular Imaging|March 7, 2023
Monitoring tafamidis treatment with quantitative SPECT/CT in transthyretin amyloid cardiomyopathyRené Rettl, Tim Wollenweber, Franz Duca, et al.
JACC. Cardiovascular Imaging|November 19, 2018
Diagnostic and Prognostic Utility of Cardiac Magnetic Resonance Imaging in Aortic RegurgitationAndreas A Kammerlander, Matthias Wiesinger, Franz Duca, et al.
NPJ Digital Medicine|November 18, 2025
Artificial intelligence prediction of age from echocardiography as a marker for cardiovascular diseaseMeenal Rawlani, Hirotaka Ieki, Christina Binder, et al.
Scientific Reports|May 4, 2026
Fibroblast growth factor 23 is associated with cardiac disease severity in transthyretin amyloid cardiomyopathyMahshid Eslami, Nikita Ermolaev, Christina Kronberger, et al.
Pageof 10